Cassaday & Co Wealth Management
FBT icon

Cassaday & Co Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cassaday & Co Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46K Hold
169
– – ﹤0.01% 642
2026
Q2 		$41.9K Hold
169
– – ﹤0.01% 654
2026
Q1 		$33.9K Buy
+169
New +$35K ﹤0.01% 691

Other funds holding FBT

Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Arlington Financial Advisors
Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
SFI Advisors
SFI Advisors Montclair, New Jersey $122M AUM 28.71% 1-Year Est. Return

Cassaday & Co Wealth Management's FBT Position: Q3 2026 in Review

Cassaday & Co Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 169 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Cassaday & Co Wealth Management first reported a position in FBT in Q1 2026 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Cassaday & Co Wealth Management held 169 shares of First Trust NYSE Arca Biotechnology Index Fund worth $46K as of Q3 2026.
  • Cassaday & Co Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #642 holding.
  • Cassaday & Co Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 3 quarters since.
  • 134 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.